US 8664251
Ryanodine receptor inhibitors for treatment of T-cell mediated disorders
granted A61KA61K31/4025A61K31/4178
Quick answer
US patent 8664251 (Ryanodine receptor inhibitors for treatment of T-cell mediated disorders) held by The Regents of the University of California expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4025, A61K31/4178, A61K31/422, A61K45/06